These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. In vivo mouse imaging and spectroscopy in drug discovery. Beckmann N; Kneuer R; Gremlich HU; Karmouty-Quintana H; Blé FX; Müller M NMR Biomed; 2007 May; 20(3):154-85. PubMed ID: 17451175 [TBL] [Abstract][Full Text] [Related]
6. Molecular tracers for the PET and SPECT imaging of disease. Pimlott SL; Sutherland A Chem Soc Rev; 2011 Jan; 40(1):149-62. PubMed ID: 20818455 [TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development. Bergström M; Grahnén A; Långström B Eur J Clin Pharmacol; 2003 Sep; 59(5-6):357-66. PubMed ID: 12937873 [TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography in CNS drug discovery and drug monitoring. Piel M; Vernaleken I; Rösch F J Med Chem; 2014 Nov; 57(22):9232-58. PubMed ID: 25144329 [TBL] [Abstract][Full Text] [Related]
9. Accelerating drug discovery and development through in vivo imaging. Eckelman WC Nucl Med Biol; 2002 Nov; 29(8):777-82. PubMed ID: 12453585 [No Abstract] [Full Text] [Related]
10. A rational regulatory approach for positron emission tomography imaging probes: from "first in man" to NDA approval and reimbursement. Barrio JR; Marcus CS; Hung JC; Keppler JS Mol Imaging Biol; 2004; 6(6):361-7. PubMed ID: 15564146 [TBL] [Abstract][Full Text] [Related]
13. [Biomedical imaging in pharmacology with nuclear medical imaging methodologies: positron emission tomography (PET) and single photon emission computed tomography (SPECT)]. Saji H; Iida Y Nihon Yakurigaku Zasshi; 2003 Mar; 121(3):181-91. PubMed ID: 12673952 [TBL] [Abstract][Full Text] [Related]
14. Small animal PET in preclinical studies: opportunities and challenges. Riemann B; Schäfers KP; Schober O; Schäfers M Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):215-21. PubMed ID: 18551093 [TBL] [Abstract][Full Text] [Related]
15. Advances in microscopy and complementary imaging techniques to assess the fate of drugs ex vivo in respiratory drug delivery: an invited paper. Park CW; Rhee YS; Vogt FG; Hayes D; Zwischenberger JB; DeLuca PP; Mansour HM Adv Drug Deliv Rev; 2012 Mar; 64(4):344-56. PubMed ID: 21920394 [TBL] [Abstract][Full Text] [Related]
16. Molecular imaging with copper-64. Smith SV J Inorg Biochem; 2004 Nov; 98(11):1874-901. PubMed ID: 15522415 [TBL] [Abstract][Full Text] [Related]
18. Activity-based probes: discovering new biology and new drug targets. Heal WP; Dang TH; Tate EW Chem Soc Rev; 2011 Jan; 40(1):246-57. PubMed ID: 20886146 [TBL] [Abstract][Full Text] [Related]
19. Development of PET probes for cancer imaging. Huang R; Wang M; Zhu Y; Conti PS; Chen K Curr Top Med Chem; 2015; 15(8):795-819. PubMed ID: 25732787 [TBL] [Abstract][Full Text] [Related]
20. The role of positron emission tomography within the spectrum of medical imaging. Jones T Eur J Nucl Med; 1996 Feb; 23(2):207-11. PubMed ID: 8925858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]